Avalon Pharma Reports Strong Revenue Growth Of 34% To SAR 130 Million And Net Profit Growth Of 39% To SAR 27 Million

2026-05-12

Press Release

AVALON PHARMA REPORTS STRONG REVENUE GROWTH OF 34% TO SAR
130 MILLION AND NET PROFIT GROWTH OF 39% TO SAR 27 MILLION
Commercial momentum and strategic expansion drive growth, supported by progress in strategic high-value
segments and pipeline progression

AvalonPharma 1Q 2026 PressRelease.

Avalon Pharma Reports Strong Revenue Growth Of 34% To SAR 130 Million And Net Profit Growth Of 39% To SAR 27 Million

Stay informed about the future of healthcare

Visit our newsroom today to stay up to date.